However, it remains unclear whether activating ILC2s would mediate similar antitumor effects in lung metastasis of breast cancer, since MDSCs are activated via IL-13/IL-13Rα1 signaling to induce pro-tumor effects [19,23,26]. This evidence concerns the gene IL13 and neoplasm.